Variations in Complication Rates for Elective Non-Reconstructive Breast Surgery
Philip J. Hanwright, Geoffrey S. Chow, Colton H. McNichols, Caitlin M. Connor, Karl Y. Bilimoria, John Y. S. Kim
Abstract
Philip J. Hanwright, Geoffrey S. Chow, Colton H. McNichols, Caitlin M. Connor, Karl Y. Bilimoria, John Y. S. Kim
Abstract
INTRODUCTION: As elective non-reconstructive breast surgery increases in popularity, there is greater demand for accurate multi-institutional data on post-operative outcomes. This study utilized a multi-institutional database to compare the 30-day morbidities and reoperation rates among the different types of elective non-reconstructive breast surgery. METHODS: Patients in the National Surgical Quality Improvement Program (NSQIP) database who underwent elective breast surgery between 2006 and 2010 were identified using primary CPT codes. Twenty defined morbidities were compared among mastopexy (CPT 19316), reduction mammaplasty (CPT 19318), and augmentation mammaplasty (CPT 19325) procedures using ANOVA and chi-squared tests for continuous variables and categorical variables, respectively. Logistic regression modeling was employed to identify preoperative risk factors for complications. RESULTS: Of the 4,272 patients identified, 654 underwent mastopexy, 2,779 underwent reduction mammaplasty, and 839 underwent augmentation mammaplasty. Complication rates were low in all cohorts, and patients undergoing augmentation mammaplasty had the lowest overall complication rate compared to mastopexy and reduction mammaplasty (1.43% vs. 2.75% vs. 4.64%). Patients undergoing reduction mammaplasty had a modestly elevated incidence of overall morbidity, superficial surgical site infections (SSI), and wound disruptions (P < 0.05). Moreover, thirty-day reoperation rates for mastopexy, reduction mammaplasty, and augmentation mammaplasty were low (2.60%, 1.94%, and 1.19%), as were the rates of life threatening complications (0.15%, 0.18%, and 0%). Only one death (0.02%) was observed for all 4,272 procedures. CONCLUSION: Elective breast surgery is a safe procedure with an extremely low incidence of life threatening complications and mortality. Comprehensive data collated from the NSQIP initiative adds to the literature of single surgeon or center studies. As such, the findings of this multi-institutional study may help further guide patient education and expectations on potentially deleterious outcomes.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
INTRODUCTION: As elective non-reconstructive breast surgery increases in popularity, there is greater demand for accurate multi-institutional data on post-operative outcomes. This study utilized a multi-institutional database to compare the 30-day morbidities and reoperation rates among the different types of elective non-reconstructive breast surgery. METHODS: Patients in the National Surgical Quality Improvement Program (NSQIP) database who underwent elective breast surgery between 2006 and 2010 were identified using primary CPT codes. Twenty defined morbidities were compared among mastopexy (CPT 19316), reduction mammaplasty (CPT 19318), and augmentation mammaplasty (CPT 19325) procedures using ANOVA and chi-squared tests for continuous variables and categorical variables, respectively. Logistic regression modeling was employed to identify preoperative risk factors for complications. RESULTS: Of the 4,272 patients identified, 654 underwent mastopexy, 2,779 underwent reduction mammaplasty, and 839 underwent augmentation mammaplasty. Complication rates were low in all cohorts, and patients undergoing augmentation mammaplasty had the lowest overall complication rate compared to mastopexy and reduction mammaplasty (1.43% vs. 2.75% vs. 4.64%). Patients undergoing reduction mammaplasty had a modestly elevated incidence of overall morbidity, superficial surgical site infections (SSI), and wound disruptions (P < 0.05). Moreover, thirty-day reoperation rates for mastopexy, reduction mammaplasty, and augmentation mammaplasty were low (2.60%, 1.94%, and 1.19%), as were the rates of life threatening complications (0.15%, 0.18%, and 0%). Only one death (0.02%) was observed for all 4,272 procedures. CONCLUSION: Elective breast surgery is a safe procedure with an extremely low incidence of life threatening complications and mortality. Comprehensive data collated from the NSQIP initiative adds to the literature of single surgeon or center studies. As such, the findings of this multi-institutional study may help further guide patient education and expectations on potentially deleterious outcomes.
Key concepts: Medicine, Mastopexy, Mammaplasty, Surgery, Breast surgery, Complication, Incidence (geometry), Breast reduction